Location · Iowa City, IA
Clinical trials in Iowa City, IA
138 recruiting studies have a site in Iowa City, and 49 of them accept healthy volunteers.
138 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Laboratoires Thea
- Location
- Iowa City, IA + 3 other US sites
- Eligibility basics
- Ages 6+
- RecruitingPhase 2
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Novartis Pharmaceuticals
- Location
- Iowa City, IA + 4 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
Motif Neurotech, Inc.
- Location
- Iowa City, IA + 2 other US sites
- Eligibility basics
- Ages 22–85
- RecruitingPhase 3
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Pfizer
- Location
- Iowa City, IA + 28 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
ADARx Pharmaceuticals, Inc.
- Location
- Iowa City, IA + 6 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Valencia Technologies Corporation
- Location
- Iowa City, IA + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
AstraZeneca
- Location
- Iowa City, IA + 2 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Lumos Pharma
- Location
- Iowa City, IA + 30 other US sites
- Eligibility basics
- Ages 3–11
- RecruitingPhase 3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Novo Nordisk A/S
- Location
- Iowa City, IA + 13 other US sites
- Eligibility basics
- Ages 10–18
- RecruitingPhase 1/Phase 2
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With…
Cabaletta Bio
- Location
- Iowa City, IA + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
UCB Biopharma SRL
- Location
- Iowa City, IA + 61 other US sites
- Eligibility basics
- Ages 16+
- RecruitingPhase 4
Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
Sanofi
- Location
- Iowa City, IA + 2 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Sanofi
- Location
- Iowa City, IA + 18 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Renal Pelvic Denervation Pilot Trial
Verve Medical, Inc
- Location
- Iowa City, IA + 7 other US sites
- Eligibility basics
- Ages 21–80
- RecruitingPhase 3
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Bausch Health Americas, Inc.
- Location
- Iowa City, IA + 36 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase 3 Trial of Reltodecacog Alfa (VMX-C001) vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.
VarmX B.V.
- Location
- Iowa City, IA + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults
Pfizer
- Location
- Iowa City, IA + 12 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Onyx™ Liquid Embolic IDE Clinical Study
Medtronic Endovascular
- Location
- Iowa City, IA + 19 other US sites
- Eligibility basics
- Ages 22+
- Recruiting
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
phenox Inc.
- Location
- Iowa City, IA + 24 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
Medtronic Neurovascular Clinical Affairs
- Location
- Iowa City, IA + 24 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia
Larimar Therapeutics, Inc.
- Location
- Iowa City, IA + 6 other US sites
- Eligibility basics
- Ages 2–60
- RecruitingPhase 1/Phase 2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Hoffmann-La Roche
- Location
- Iowa City, IA + 2 other US sites
- Eligibility basics
- Ages 2–59 · Men only
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Eli Lilly and Company
- Location
- Iowa City, IA + 3 other US sites
- Eligibility basics
- Ages 1–35
- RecruitingPhase 2
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
argenx
- Location
- Iowa City, IA + 10 other US sites
- Eligibility basics
- Ages 5–17